Loading clinical trials...
Loading clinical trials...
A Phase I, Open-label, Randomized, Crossover Trial in 20 Healthy Subjects to Investigate the Pharmacokinetic Interactions Between the Combination of Efavirenz and Tenofovir Disoproxil Fumarate and Different Dosages of Telaprevir.
Conditions
Interventions
Efavirenz; Tenofovir disoproxil fumarate; Telaprevir
Start Date
February 1, 2009
Primary Completion Date
April 1, 2009
Completion Date
April 1, 2009
Last Updated
December 17, 2010
NCT04929028
NCT07071623
NCT01875588
NCT07199335
NCT03087253
NCT05419024
Lead Sponsor
Tibotec BVBA
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions